Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections

NCT00368537 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

550

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Diseases, Bacterial

Interventions

DRUG: Tigecycline
DRUG: ampicillin-sulbactam

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer